Dr Ajaz Hussain gave a very interesting presentation as part of his Special Address at FDD Conclave 2021 on how and why S.M.A.R.T Pharmaceuticals, as a category, is poised to dominate the market in this decade. He said that they should not be confused with ‘smart pharmaceuticals’ such as digital therapeutics and pills with embedded sensors that digitally track behaviours and described S.M.A.R.T as an acronym for Specific Self, Measurable Monitoring, Achievable Analysis, Relevant Reporting and Timely Technology.
Dr Hussain also advised the life sciences industry to hone their adaptive learning skills to remain relevant in the coming times and gave some points for consideration while investing in S.M.A.R.T objectives and tools. He said that it is time for the life sciences sector to get ready for an era of rapid change and this necessitates the adoption of a smart ‘development stance’ to prepare for 2022 and beyond. His advice was that a mix of the right education, training and experience is vital for this.
Moving on, he said that as the pharma industry embarks on a journey of transformation driven by technology it has to ensure data integrity. He asserted that it is vital to build a culture of GMP and opined that empowered workers are the key to data integrity. He ended the session with the take away that the need of the hour for the industry is to be self-transforming and the step to get there is self-authorship.